×

Enhanced drug delivery in transdermal systems

  • US 7,456,159 B2
  • Filed: 12/30/2002
  • Issued: 11/25/2008
  • Est. Priority Date: 06/18/2001
  • Status: Expired due to Term
First Claim
Patent Images

1. A method of adjusting the blood level profile or permeation of a drug from a transdermal drug delivery composition, comprising:

  • (a) selecting a parent drug and a corresponding prodrug, wherein the parent drug is a steroid and the prodrug is a corresponding steroid derivative that provides a source of therapeutically active steroid;

    (b) combining the parent drug and prodrug in a carrier that includes at least one pressure-sensitive adhesive, wherein the steroid and corresponding steroid derivative are present in a wt/wt ratio of from 10;

    1 to 1;

    10 steroid;

    corresponding steroid derivative;

    (c) measuring the permeation and/or blood level profile of the drug;

    (d) adjusting at least one of;

    (i) the selection of the corresponding prodrug and (ii) the relative concentration of the parent drug and prodrug,wherein the parent drug is a steroid comprising a steroid ring with a free hydroxy group at position 3, 11 or 17 and the prodrug is a corresponding steroid derivative where the free hydroxy group at the 3, 11 or 17 position has been reacted with an alcohol moiety.

View all claims
  • 0 Assignments
Timeline View
Assignment View
    ×
    ×